Last 12 months
Inside the activity.
1 purchase rows · 87 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 20 |
| Jan 2026 | 0 | 13 |
| Feb 2026 | 1 | 4 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2026 Filed Feb 27, 2026 02:30 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
SaleSeries A Common Stock | 39,644 | $16.38 | $649,368.72 |
DisclosureSEC source: 0001470831-26-000222 · wk-form4_1772159407.xml · nonDerivative · entry 3 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.83 to $16.53 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 24, 2026 Filed Feb 27, 2026 02:30 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
SaleSeries A Common Stock | 160,356 | $16.86 | $2,703,602.16 |
DisclosureSEC source: 0001470831-26-000222 · wk-form4_1772159407.xml · nonDerivative · entry 2 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,644 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.535 to $17.53 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 24, 2026 Filed Feb 27, 2026 02:30 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
ConversionSeries A Common Stock | 200,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-26-000222 · wk-form4_1772159407.xml · nonDerivative · entry 1 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 200,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F2 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 21:16 UTC |
Edmond LandonChief Legal Officer
|
ConversionSeries B Common Stock · Derivative | 11,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000164 · wk-form4_1771449384.xml · derivative · entry 5 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Series A Common Stock · 11,052 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 21:16 UTC |
Edmond LandonChief Legal Officer
|
ConversionSeries A Common Stock | 11,052 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-26-000164 · wk-form4_1771449384.xml · nonDerivative · entry 3 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 341,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F4 · balance_after: Consists of (i) 113,414 shares of Series A Common Stock and (ii) 228,407 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:16 UTC |
Edmond LandonChief Legal Officer
|
ConversionSeries B Common Stock · Derivative | 11,448 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000164 · wk-form4_1771449384.xml · derivative · entry 4 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,052 Underlying: Series A Common Stock · 11,448 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: Represents 11,448 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:16 UTC |
Edmond LandonChief Legal Officer
|
Tax withholdingSeries A Common Stock | 24,561 | $18.60 | $456,834.60 |
DisclosureSEC source: 0001470831-26-000164 · wk-form4_1771449384.xml · nonDerivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,769 F3 · kind: Represents shares of Series A Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:16 UTC |
Edmond LandonChief Legal Officer
|
ConversionSeries A Common Stock | 11,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-26-000164 · wk-form4_1771449384.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 355,330 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents 11,448 shares of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), automatically converted into shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:15 UTC |
Galvin CarmelChief People Officer
|
Tax withholdingSeries A Common Stock | 23,050 | $18.60 | $428,730.00 |
DisclosureSEC source: 0001470831-26-000162 · wk-form4_1771449309.xml · nonDerivative · entry 1 Galvin Carmel · CIK 0001733091 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 616,810 F1 · kind: Represents shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). F2 · balance_after: Consists of (i) 130,487 shares of Series A Common Stock and (ii) 486,323 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:13 UTC |
Fernandez Gomez LucianoDirector · Co-Chief Executive Officer
|
Tax withholdingSeries A Common Stock | 23,308 | $18.60 | $433,528.80 |
DisclosureSEC source: 0001470831-26-000159 · wk-form4_1771449230.xml · nonDerivative · entry 1 Fernandez Gomez Luciano · CIK 0001730978 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,347,583 F1 · kind: Represents shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). F2 · balance_after: Consists of (i) 145,874 shares of Series A Common Stock; (ii) 1,008,471 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan (the "Plan"), each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement; and (iii) 1,193,238 unvested performance stock units awarded under the Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:12 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries B Common Stock · Derivative | 29,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000157 · wk-form4_1771449150.xml · derivative · entry 7 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 301,405 Underlying: Series A Common Stock · 29,513 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F5 · kind: Represents 29,513 shares of Series B Common Stock automatically converted into shares of Series A Common Stock in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F8 · balance_after: Consists of (i) 267,030 shares of Series B Common Stock and (ii) 34,375 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:12 UTC |
Whalen AmandaChief Financial Officer
|
Tax withholdingSeries A Common Stock | 45,307 | $18.60 | $842,710.20 |
DisclosureSEC source: 0001470831-26-000157 · wk-form4_1771449150.xml · nonDerivative · entry 5 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 426,425 F6 · kind: Represents shares of Series A Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs. F7 · balance_after: Consists of (i) 66,394 shares of Series A Common Stock and (ii) 360,031 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 21:12 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries A Common Stock | 29,513 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-26-000157 · wk-form4_1771449150.xml · nonDerivative · entry 4 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 471,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Represents 29,513 shares of Series B Common Stock automatically converted into shares of Series A Common Stock in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). F2 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:12 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries B Common Stock · Derivative | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000157 · wk-form4_1771449150.xml · derivative · entry 6 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 330,918 Underlying: Series A Common Stock · 14,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F2 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:12 UTC |
Whalen AmandaChief Financial Officer
|
SaleSeries A Common Stock | 4,719 | $18.63 | $87,914.97 |
DisclosureSEC source: 0001470831-26-000157 · wk-form4_1771449150.xml · nonDerivative · entry 3 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 442,219 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.52 to $18.75 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:12 UTC |
Whalen AmandaChief Financial Officer
|
SaleSeries A Common Stock | 9,281 | $19.01 | $176,431.81 |
DisclosureSEC source: 0001470831-26-000157 · wk-form4_1771449150.xml · nonDerivative · entry 2 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 446,938 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.76 to $19.75 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:12 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries A Common Stock | 14,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-26-000157 · wk-form4_1771449150.xml · nonDerivative · entry 1 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 456,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F2 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:26 UTC |
Ceran JenniferDirector
|
PurchaseSeries A Common Stock | 16,339 | $18.38 | $300,310.82 |
DisclosureSEC source: 0001470831-26-000142 · wk-form4_1771363568.xml · nonDerivative · entry 1 Ceran Jennifer · CIK 0001652155 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,691 F1 · shares: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $18.36 to $18.38 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected. F2 · balance_after: Consists of (i) 24,871 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 5,820 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| January 29, 2026 Filed Jan 30, 2026 21:30 UTC |
Shopify Strategic Holdings 3 LLC10% owner
SHOPIFY INC.10% owner
|
OtherSeries B Common Stock · Derivative | 344,383 | $0.01 | $3,443.83 |
DisclosureSEC source: 0001193125-26-031887 · ownership.xml · derivative · entry 2 Shopify Strategic Holdings 3 LLC · CIK 0001993562 · 10% owner SHOPIFY INC. · CIK 0001594805 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,628,727 Underlying: Series A Common Stock · 344,383 shares Expires not disclosed F3 · derivative.exercise_price: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock of the Issuer, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F3 · derivative.exercise_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock of the Issuer, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F3 · derivative.expiration_date: Each share of Series B Common Stock is convertible at any time at the option of the holder into one share of Series A Common Stock of the Issuer, and will automatically convert into Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · ownership.direct: Reflects securities held directly by Shopify Strategic Holdings 3 LLC, a wholly-owned subsidiary of Shopify Inc. ("Shopify"). Shopify is an indirect beneficial owner and disclaims beneficial ownership except to the extent of its pecuniary interest therein. Read SEC document |
| January 29, 2026 Filed Jan 30, 2026 21:30 UTC |
Shopify Strategic Holdings 3 LLC10% owner
SHOPIFY INC.10% owner
|
OtherWarrants to Purchase Series B Common Stock (Right to Buy) · Derivative | 344,383 | $0.00 Strike: $0.01 | $0.00 |
DisclosureSEC source: 0001193125-26-031887 · ownership.xml · derivative · entry 1 Shopify Strategic Holdings 3 LLC · CIK 0001993562 · 10% owner SHOPIFY INC. · CIK 0001594805 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,066,293 Underlying: Series B Common Stock · 344,383 shares Expires 2032-07-28 F1 · derivative.exercise_date: 25% of the shares subject to the warrants vested on July 28, 2022, and the remaining shares vest quarterly in equal amounts through July 28, 2027. Notwithstanding the foregoing, in connection with the Issuer's initial public offering ("IPO"), 25% of the total number of shares subject to the warrants vested immediately prior to the completion of the IPO. F2 · ownership.direct: Reflects securities held directly by Shopify Strategic Holdings 3 LLC, a wholly-owned subsidiary of Shopify Inc. ("Shopify"). Shopify is an indirect beneficial owner and disclaims beneficial ownership except to the extent of its pecuniary interest therein. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:29 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
ConversionSeries B Common Stock · Derivative | 155,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000061 · wk-form4_1769722181.xml · derivative · entry 4 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,950,945 Underlying: Series A Common Stock · 155,219 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F2 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:29 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
SaleSeries A Common Stock | 4,530 | $24.94 | $112,978.20 |
DisclosureSEC source: 0001470831-26-000061 · wk-form4_1769722181.xml · nonDerivative · entry 3 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.82 to $25.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:29 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
SaleSeries A Common Stock | 150,689 | $25.34 | $3,818,459.26 |
DisclosureSEC source: 0001470831-26-000061 · wk-form4_1769722181.xml · nonDerivative · entry 2 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,530 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.01 to $26.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 27, 2026 Filed Jan 29, 2026 21:29 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
ConversionSeries A Common Stock | 155,219 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-26-000061 · wk-form4_1769722181.xml · nonDerivative · entry 1 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 155,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F2 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 21:29 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
ConversionSeries B Common Stock · Derivative | 167,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000051 · wk-form4_1769117357.xml · derivative · entry 4 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,106,164 Underlying: Series A Common Stock · 167,926 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F2 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 21:29 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
SaleSeries A Common Stock | 796 | $23.29 | $18,538.84 |
DisclosureSEC source: 0001470831-26-000051 · wk-form4_1769117357.xml · nonDerivative · entry 3 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.15 to $23.46 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 21:29 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
SaleSeries A Common Stock | 167,130 | $24.16 | $4,037,860.80 |
DisclosureSEC source: 0001470831-26-000051 · wk-form4_1769117357.xml · nonDerivative · entry 2 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 796 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.48 to $24.46 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 21:29 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
ConversionSeries A Common Stock | 167,926 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-26-000051 · wk-form4_1769117357.xml · nonDerivative · entry 1 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 167,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F2 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:04 UTC |
Edmond LandonChief Legal Officer
|
SaleSeries A Common Stock | 4,399 | $25.52 | $112,262.48 |
DisclosureSEC source: 0001470831-26-000039 · wk-form4_1768597468.xml · nonDerivative · entry 2 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 343,882 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.36 to $25.68 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · balance_after: Consists of (i) 90,284 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 253,598 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:04 UTC |
Edmond LandonChief Legal Officer
|
SaleSeries A Common Stock | 5,601 | $26.08 | $146,074.08 |
DisclosureSEC source: 0001470831-26-000039 · wk-form4_1768597468.xml · nonDerivative · entry 1 Edmond Landon · CIK 0001991399 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 348,281 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.80 to $26.73 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:08 UTC |
Fernandez Gomez LucianoDirector · Co-Chief Executive Officer
|
GrantSeries A Common Stock | 1,193,238 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000043 · wk-form4_1768597727.xml · nonDerivative · entry 2 Fernandez Gomez Luciano · CIK 0001730978 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,370,891 F2 · shares: Represents performance stock units ("PSUs") awarded under the Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. The PSUs will vest in up to four tranches over a five-year measurement period, subject to the achievement of specified performance targets tied to the trading price of the Series A Common Stock and the Reporting Person's continued service as the Issuer's co-Chief Executive Officer through the applicable vesting date. Each tranche of PSUs will vest only if the trading price of the Series A Common Stock closes at or above a specified dollar value for a period of at least sixty consecutive calendar days during the applicable measurement period. The stock price targets for tranches 1 through 4 are $40.00, $55.00, $70.00, and $85.00 per share, respectively, subject to proportionate adjustment in the event of any stock split or other similar change in the Issuer's capital stock. F3 · balance_after: Consists of (i) 78,032 shares of Series A Common Stock; (ii) 1,099,621 unvested RSUs awarded under the Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement; and (iii) 1,193,238 unvested PSUs awarded under the Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:08 UTC |
Fernandez Gomez LucianoDirector · Co-Chief Executive Officer
|
GrantSeries A Common Stock | 1,093,801 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000043 · wk-form4_1768597727.xml · nonDerivative · entry 1 Fernandez Gomez Luciano · CIK 0001730978 · Director · Co-Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,177,653 F1 · shares: Represents restricted stock units ("RSUs") awarded under the Issuer's 2023 Stock Option and Incentive Plan (the "Plan"), each representing the contingent right to receive one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), upon vesting and settlement. The RSUs will vest in twelve equal quarterly installments, with the first such installment vesting on February 15, 2026, subject to the Reporting Person's continued service as the Issuer's co-Chief Executive Officer on each such vesting date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:06 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries B Common Stock · Derivative | 4,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000041 · wk-form4_1768597559.xml · derivative · entry 4 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 344,918 Underlying: Series A Common Stock · 4,045 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F2 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F6 · balance_after: Consists of (i) 235,543 shares of Series B Common Stock and (ii) 109,375 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:06 UTC |
Whalen AmandaChief Financial Officer
|
SaleSeries A Common Stock | 6,174 | $25.52 | $157,560.48 |
DisclosureSEC source: 0001470831-26-000041 · wk-form4_1768597559.xml · nonDerivative · entry 3 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 442,219 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.295 to $25.68 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · balance_after: Consists of (i) 42,687 shares of Series A Common Stock and (ii) 399,532 unvested restricted stock units ("RSUs") awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:06 UTC |
Whalen AmandaChief Financial Officer
|
SaleSeries A Common Stock | 7,826 | $26.08 | $204,102.08 |
DisclosureSEC source: 0001470831-26-000041 · wk-form4_1768597559.xml · nonDerivative · entry 2 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 448,393 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.78 to $26.73 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:06 UTC |
Whalen AmandaChief Financial Officer
|
ConversionSeries A Common Stock | 4,045 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-26-000041 · wk-form4_1768597559.xml · nonDerivative · entry 1 Whalen Amanda · CIK 0001991131 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 456,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. F2 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 23:02 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
ConversionSeries B Common Stock · Derivative | 140,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000037 · wk-form4_1768518127.xml · derivative · entry 4 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,274,090 Underlying: Series A Common Stock · 140,646 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F2 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 23:02 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
SaleSeries A Common Stock | 90,327 | $27.29 | $2,465,023.83 |
DisclosureSEC source: 0001470831-26-000037 · wk-form4_1768518127.xml · nonDerivative · entry 3 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.10 to $27.42 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 23:02 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
SaleSeries A Common Stock | 50,319 | $27.62 | $1,389,810.78 |
DisclosureSEC source: 0001470831-26-000037 · wk-form4_1768518127.xml · nonDerivative · entry 2 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 90,327 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.425 to $28.42 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 23:02 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
ConversionSeries A Common Stock | 140,646 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-26-000037 · wk-form4_1768518127.xml · nonDerivative · entry 1 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F2 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 21:31 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
ConversionSeries B Common Stock · Derivative | 16,649 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000022 · wk-form4_1767907885.xml · derivative · entry 7 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,414,736 Underlying: Series A Common Stock · 16,649 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F2 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 21:31 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
SaleSeries A Common Stock | 16,649 | $30.01 | $499,636.49 |
DisclosureSEC source: 0001470831-26-000022 · wk-form4_1767907885.xml · nonDerivative · entry 5 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.06 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 21:31 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
ConversionSeries A Common Stock | 16,649 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-26-000022 · wk-form4_1767907885.xml · nonDerivative · entry 4 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,649 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F2 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:31 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
ConversionSeries B Common Stock · Derivative | 137,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000022 · wk-form4_1767907885.xml · derivative · entry 6 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,431,385 Underlying: Series A Common Stock · 137,504 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F2 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:31 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
SaleSeries A Common Stock | 2,382 | $28.52 | $67,934.64 |
DisclosureSEC source: 0001470831-26-000022 · wk-form4_1767907885.xml · nonDerivative · entry 3 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.42 to $28.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:31 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
SaleSeries A Common Stock | 135,122 | $28.92 | $3,907,728.24 |
DisclosureSEC source: 0001470831-26-000022 · wk-form4_1767907885.xml · nonDerivative · entry 2 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,382 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.545 to $29.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 21:31 UTC |
Bialecki AndrewDirector · Co-Chief Executive Officer · 10% owner
|
ConversionSeries A Common Stock | 137,504 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001470831-26-000022 · wk-form4_1767907885.xml · nonDerivative · entry 1 Bialecki Andrew · CIK 0001991099 · Director · Co-Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 137,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F2 · price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:06 UTC |
Bialecki AndrewDirector · Chief Executive Officer · 10% owner
|
ConversionSeries B Common Stock · Derivative | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-25-000452 · wk-form4_1766523997.xml · derivative · entry 4 Bialecki Andrew · CIK 0001991099 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,568,889 Underlying: Series A Common Stock · 100,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F2 · derivative.exercise_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. F2 · derivative.expiration_date: Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:06 UTC |
Bialecki AndrewDirector · Chief Executive Officer · 10% owner
|
SaleSeries A Common Stock | 6,934 | $31.94 | $221,471.96 |
DisclosureSEC source: 0001470831-25-000452 · wk-form4_1766523997.xml · nonDerivative · entry 3 Bialecki Andrew · CIK 0001991099 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.57 to $32.30 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 22, 2025 Filed Dec 23, 2025 21:06 UTC |
Bialecki AndrewDirector · Chief Executive Officer · 10% owner
|
SaleSeries A Common Stock | 93,066 | $33.05 | $3,075,831.30 |
DisclosureSEC source: 0001470831-25-000452 · wk-form4_1766523997.xml · nonDerivative · entry 2 Bialecki Andrew · CIK 0001991099 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,934 F1 · kind: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.38 to $33.35 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.